These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15914275)

  • 1. Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants.
    Fu YG; Sung JJ; Wu KC; Wu HP; Yu J; Chan M; Chan VY; Chan KK; Fan DM; Leung WK
    Cancer Lett; 2005 Jun; 224(2):243-52. PubMed ID: 15914275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
    Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
    J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
    Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
    Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
    Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H
    J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
    Eibl G; Takata Y; Boros LG; Liu J; Okada Y; Reber HA; Hines OJ
    Cancer Res; 2005 Feb; 65(3):982-90. PubMed ID: 15705899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma.
    Leung WK; To KF; Go MY; Chan KK; Chan FK; Ng EK; Chung SC; Sung JJ
    Int J Oncol; 2003 Nov; 23(5):1317-22. PubMed ID: 14532971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The potential role of Id1 in COX-2 mediated angiogenesis in gastric cancer].
    Lei T; Han S; Guo XY; Ding R; Li Y; Xie HH; Bai FH; Wu KC; Ding J
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1570-5. PubMed ID: 17785115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of selective cyclooxygenase-2 inhibitor on proliferation of human gastric cancer cells].
    Li JY; Yu JP; Luo HS; Yu BP; Tian G; Mei Q; Huang JA
    Ai Zheng; 2002 Jun; 21(6):625-9. PubMed ID: 12452063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 in cancer cells and macrophages induces colon cancer cell growth by cigarette smoke extract.
    Liu ES; Shin VY; Ye YN; Luo JC; Wu WK; Cho CH
    Eur J Pharmacol; 2005 Jul; 518(1):47-55. PubMed ID: 15993407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis.
    Zhao QT; Yue SQ; Cui Z; Wang Q; Cui X; Zhai HH; Zhang LH; Dou KF
    Life Sci; 2007 Jan; 80(5):484-92. PubMed ID: 17097688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of prostate cancer cell lines to COX-2 inhibitor treatment.
    Wagner M; Loos J; Weksler N; Gantner M; Corless CL; Barry JM; Beer TM; Garzotto M
    Biochem Biophys Res Commun; 2005 Jul; 332(3):800-7. PubMed ID: 15907789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase inhibitors not inhibit resting lung cancer A549 cell proliferation.
    Duan W; Zhang L
    Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):317-21. PubMed ID: 16618538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms.
    Zhong H; Willard M; Simons J
    Int J Cancer; 2004 Nov; 112(4):585-95. PubMed ID: 15382039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo.
    Buerkle MA; Lehrer S; Sohn HY; Conzen P; Pohl U; Krötz F
    Circulation; 2004 Oct; 110(14):2053-9. PubMed ID: 15451781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.
    Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y
    Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of angiogenesis in pancreatic carcinoma by cyclooxygenase-2 antisense oligodeoxynucleotides].
    Wang XP; Xie CG; Dong YW; Zhang RL; Wu LY; Wu K
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1501-4. PubMed ID: 14521730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts.
    Miura S; Tatsuguchi A; Wada K; Takeyama H; Shinji Y; Hiratsuka T; Futagami S; Miyake K; Gudis K; Mizokami Y; Matsuoka T; Sakamoto C
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G444-51. PubMed ID: 15246970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.